Pkp.Ax
PKP.AX operates in the Pharmaceuticals industry, focusing on Pharmaceuticals & Medical Research, and generates revenue primarily through the development and sale of pharmaceutical products.
Business. PKP.AX operates in the Pharmaceuticals industry, focusing on Pharmaceuticals & Medical Research, and generates revenue primarily through the development and sale of pharmaceutical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
PKP.AX operates in the Pharmaceuticals industry, focusing on Pharmaceuticals & Medical Research, and generates revenue primarily through the development and sale of pharmaceutical products.
The company's capital structure is characterized by a negative total equity of -574,000 AUD and a debt-to-equity ratio of -10.65, indicating a highly leveraged position with significant long-term debt of 6,114,000 AUD. Liquidity is constrained, as evidenced by a current ratio of 0.66 and a negative operating cash flow of -8,407,000 AUD, suggesting the company is not generating sufficient cash from operations to meet short-term obligations.
Profitability is a concern, with a net loss of 8,347,000 AUD and an operating loss of 3,983,000 AUD. The return on equity is 14.54%, which is high in absolute terms but misleading due to the negative equity base. The return on assets is -0.41%, indicating that the company is not generating returns that cover its cost of capital.
Geographically and segment-wise, the company's exposure is not disclosed in the available data, but the negative net cash position after subtracting total debt suggests a concentration of risk in its core operations.
Growth trajectory is negative, with a net loss and negative operating and free cash flows. The company's revenue of 15,562,000 AUD is not sufficient to cover its operating costs, and there is no indication of improvement in the near term.
Risk factors include medium liquidity risk and a negative net cash position after subtracting total debt. The dilution potential is low, but the company's negative equity and high debt levels could lead to further financial stress.
Recent events include a significant net loss and negative cash flows, which are indicative of operational challenges. No specific recent filings or transcripts are cited in the available data to provide further context.
- The company is highly leveraged with a negative equity position and a debt-to-equity ratio of -10.65.
- Profitability is a major concern, with a net loss and negative operating income.
- Liquidity is constrained, as shown by a current ratio of 0.66 and negative operating cash flow.
- The company's growth trajectory is negative, with no signs of improvement in the near term.
- Risk factors include medium liquidity risk and a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- PKP.AX Market data — financials · 2026-05-28